Loading market dashboard
Vext Science, Inc.
VEXTFHealthcareOTCUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
A high-visibility location on one of the area's busiest retail corridors, anchored by neighboring Jungle Jim's International Market - expected to drive durable store-level performance. Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with operations in Arizona and Ohio, today announced that its Herbal Wellness Center dispensary in Fairfield, Ohio (the "Dispensary") has commenced operations and is now open to the public for both medical and adult-use sales.
Vext Science Inc. (VEXTF) Q1 2026 Earnings Call Transcript
Revenue of $12.2 million, up 5.2% year-over-year; gross profit more than doubled to $5.5 million (45.4% margin), and net loss narrowed 73.2% to $(0.9) million. Operating cash flow of $1.6 million and cash position of $5.5 million at quarter-end.
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with operations in Arizona and Ohio, today announced that it has entered into an investor relations agreement (the "Services Agreement") with Zuanic & Associates ("Zuanic"). Pursuant to the Services Agreement, Zuanic will provide advisory, research and investor relations services to the Company over a twelve-month term, beginning on May 15, 2026, for a monthly cash fee not exceeding US$7,000.
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announced that the Company expects to release its financial results for the period ended March 31, 2026, before market open on Thursday, May 21, 2026. The Company will host a conference call and webcast on the same day at 08:00 am ET to discuss the financial results for the first quarter of 2026.
Vext Science Inc. (VEXTF) Q4 2025 Earnings Call Transcript
Fiscal 2025 revenue of $51.4 million, up +43% YoY, with EBITDA* of $5 million and Adjusted EBITDA* of $10.9 million; net cash provided by operating activities of $11.7 million, up +256% (+$8.4 million) YoY. Margins expected to improve as newer Ohio retail locations ramp and the retail base continues to stabilize.
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announced that further to its previous disclosure regarding the timing of its fourth quarter and full year 2025 financial results release and conference call, the Company now expects to release its financial results for the period ended December 31, 2025, before market open on Wednesday, April 29, 2026. The Company will host a conference call and webcast on the same day at 08:00 am ET to discuss the financial results for the fourth quarter and full year 2025.
Strategic closure and planned sale of Eloy cultivation facility expected to improve Arizona profitability and enhance free cash flow. Proceeds from the sale to facilitate debt reduction, with key equipment redeployed to the Ohio market, saving approximately $2 million in capital expenditures to support Vext's build-out in the State.
